» Articles » PMID: 36158686

A Comprehensive Review on MiR-153: Mechanistic and Controversial Roles of MiR-153 in Tumorigenicity of Cancer Cells

Overview
Journal Front Oncol
Specialty Oncology
Date 2022 Sep 26
PMID 36158686
Authors
Affiliations
Soon will be listed here.
Abstract

miRNAs play a crucial role in regulating genes involved in cancer progression. Recently, miR-153 has been mainly well-known as a tumor suppressive miRNA modulating genes in proliferation, metastasis, EMT, angiogenesis and drug resistance ability of a variety types of cancer. Mechanistic activity of miR-153 in tumorigenicity has not been fully reviewed. This manuscript presents a comprehensive review on the tumor suppressive activity of miR-153 as well as introducing the controversial role of miR-153 as an oncogenic miRNA in cancer. Furthermore, it summarizes all potential non-coding RNAs such as long non-coding RNAs (LncRNAs), transcribed ultra-conserved regions (T-UCRs) and circular RNAs (CircRNAs) targeting and sponging miR-153. Understanding the critical role of miR-153 in cell growth, metastasis, angiogenesis and drug resistance ability of cancer cells, suggests miR-153 as a potential prognostic biomarker for detecting cancer as well as providing a novel treatment strategy to combat with several types of cancer.

Citing Articles

Comprehensive computational analysis of differentially expressed miRNAs and their influence on transcriptomic signatures in prostate cancer.

Aldakheel F, Alnajran H, Mateen A, Alduraywish S, AlQahtani M, Syed R Sci Rep. 2025; 15(1):3646.

PMID: 39881138 PMC: 11779938. DOI: 10.1038/s41598-025-85502-4.


A comprehensive review on lncRNA LOXL1-AS1: molecular mechanistic pathways of lncRNA LOXL1-AS1 in tumorigenicity of cancer cells.

Yousefnia S Front Oncol. 2024; 14:1384342.

PMID: 39136001 PMC: 11317273. DOI: 10.3389/fonc.2024.1384342.


How MicroRNAs Command the Battle against Cancer.

Wu H, Leng S, Sergi C, Leng R Int J Mol Sci. 2024; 25(11).

PMID: 38892054 PMC: 11172831. DOI: 10.3390/ijms25115865.


The seeds of its regulation: Natural antisense transcripts as single-gene control switches in neurodegenerative disorders.

Lahiri D, Maloney B, Wang R, White F, Sambamurti K, Greig N Ageing Res Rev. 2024; 99:102336.

PMID: 38740308 PMC: 11492926. DOI: 10.1016/j.arr.2024.102336.


MiR-153 is Involved in Testicular Ischemia/Reperfusion Injury by Directly Targeting FOXO3 and Regulating Spermatogonia Pyroptosis.

Ning J, Wang J, Xu L, Li H Mol Biotechnol. 2024; .

PMID: 38664304 DOI: 10.1007/s12033-024-01156-z.


References
1.
Tezcan G, Aksoy S, Tunca B, Bekar A, Mutlu M, Cecener G . Oleuropein modulates glioblastoma miRNA pattern different from leaf extract. Hum Exp Toxicol. 2019; 38(9):1102-1110. DOI: 10.1177/0960327119855123. View

2.
Liu D, Gao M, Wu K, Zhu D, Yang Y, Zhao S . LINC00152 facilitates tumorigenesis in esophageal squamous cell carcinoma via miR-153-3p/FYN axis. Biomed Pharmacother. 2019; 112:108654. DOI: 10.1016/j.biopha.2019.108654. View

3.
Liang H, Ge F, Xu Y, Xiao J, Zhou Z, Liu R . miR-153 inhibits the migration and the tube formation of endothelial cells by blocking the paracrine of angiopoietin 1 in breast cancer cells. Angiogenesis. 2018; 21(4):849-860. PMC: 6208884. DOI: 10.1007/s10456-018-9630-9. View

4.
Wang Y, Wu N, Zhang J, Wang H, Men X . MiR-153-5p Enhances the Sensitivity of Triple-Negative Breast Cancer Cells to Paclitaxel by Inducing G2M Phase Arrest. Onco Targets Ther. 2020; 13:4089-4097. PMC: 7231778. DOI: 10.2147/OTT.S241640. View

5.
Xu J, Liao X, Lu N, Liu W, Wong C . Chromatin-modifying drugs induce miRNA-153 expression to suppress Irs-2 in glioblastoma cell lines. Int J Cancer. 2011; 129(10):2527-31. DOI: 10.1002/ijc.25917. View